Article labels and scales
- After Effects
- Duration stage 5 of 6: residual effects after the main experience · not comedownDuration stage
734 matching source locations · Partial coverage
- 1,4-Butanediol · Duration > oral > After Effects
- 1B-LSD · Duration > oral > After Effects
- 1cP-AL-LAD · Duration > oral > After Effects
- Buccal
- Route: absorbed through the cheek lining · not Sublingual (under the tongue)Route of administration
14 matching source locations · Partial coverage
- 25c-NBOMe · Field: dosage.routes[1].notes
- 25I-NBOH · Field: subjective_effects.notes.overview
- Buprenorphine · Field: pharmacology.pharmacokinetics
- Caution
- Interaction tier 1 of 3: combine with care and reduced doses · advisory, not a prohibitionInteraction tier
122 matching source locations · Partial coverage
- 1B-LSD · Field: interactions.caution[5]
- 1cP-AL-LAD · Field: interactions.caution[5]
- 1cP-LSD · Field: interactions.caution[5]
- Come Up
- Duration stage 2 of 6: effects rising toward the peak · same concept as the register word come-upDuration stage
749 matching source locations · Partial coverage
- 1,4-Butanediol · Duration > oral > Come Up
- 1B-LSD · Duration > oral > Come Up
- 1cP-AL-LAD · Duration > oral > Come Up
- Confirmed
- Carcinogenicity level: an established human carcinogenCarcinogenicity level
72 matching source locations · Partial coverage
- 1cP-AL-LAD · Field: pharmacology.pharmacokinetics
- 1cP-AL-LAD · Field: summary
- 2-FMA · Field: legality.countries.New Zealand.notes
- Controlled precursor
- Legal status: a chemical regulated because it can make a controlled drug · not itself a drugLegal status
8 matching source locations · Partial coverage
- 1,4-Butanediol · Field: legality.countries.Costa Rica.status
- 1,4-Butanediol · Field: legality.countries.Russia.notes
- Ephedrine · Field: legality.countries.Australia.designation
- Dangerous
- Interaction tier 3 of 3: combination can be fatal · strongest warning, keep its full forceInteraction tier
468 matching source locations · Partial coverage
- 1,4-Butanediol · Field: legality.countries.Sweden.notes
- 1P-LSD · Field: legality.countries.Israel.instrument
- 1P-LSD · Field: legality.countries.Israel.notes
- Decriminalized
- Legal status: possession is not a criminal offence but may still be penalised · not legalLegal status
- Extremely High
- Risk level 4 of 4Risk level
22 matching source locations · Partial coverage
- 2C-C · Field: subjective_effects.sensory.visual.subcategories.Hallucinatory States.effects[1].description
- 2C-E · Field: subjective_effects.sensory.visual.subcategories.Hallucinatory States.effects[1].description
- 2C-P · Field: subjective_effects.sensory.visual.subcategories.Hallucinatory States.effects[1].description
- Extremely Low
- Risk level 1 of 4 for a harm category · a rating, not a doseRisk level
- Heavy
- Dose tier 5 of 5: dose with significant risk · an amount, not weightDose tier
1250 matching source locations · Partial coverage
- 1,4-Butanediol · Dosage > oral > Heavy
- 1B-LSD · Dosage > oral > Heavy
- 1cP-AL-LAD · Dosage > oral > Heavy
- High
- Risk level 3 of 4 · a rating · not the slang for intoxicatedRisk level
- Illegal
- Legal status: possession is a criminal offenceLegal status
1644 matching source locations · Partial coverage
- 1,4-Butanediol · Field: legality.countries.Germany.status
- 1,4-Butanediol · Field: legality.countries.New Zealand.status
- 1B-LSD · Field: legality.countries.Germany.status
- Illegal (analog/blanket ban)
- Legal status: illegal only because a law covers analogues or whole classes · not named individuallyLegal status
94 matching source locations · Partial coverage
- 1B-LSD · Field: legality.countries.United Kingdom.status
- 1cP-AL-LAD · Field: legality.countries.Germany.status
- 1cP-LSD · Field: legality.countries.United Kingdom.status
- IM
- Abbreviation of Intramuscular · use the target language's standard clinical abbreviationRoute of administration
- Inhaled
- Route: breathed in as gas or vapour · not Smoked (combustion), not Vaporized specificallyRoute of administration
- Injected
- Route: delivered by needle, any site · umbrella for IV, IM, and subcutaneousRoute of administration
- Insufflated
- Route: snorted through the nose · clinical register · pairs with IntranasalRoute of administration
25 matching source locations · Partial coverage
- 2C-B-FLY-NBOMe · Field: dosage.routes[0].notes
- 2C-I · Field: dosage.routes[1].notes
- 2C-T-7 · Field: dosage.routes[1].notes
- Intramuscular
- Route: injected into muscle · abbreviation IMRoute of administration
17 matching source locations · Partial coverage
- Desomorphine · Field: pharmacology.pharmacodynamics
- DET · Field: history_culture.content
- Dimenhydrinate · Field: legality.countries.United States.notes
- Intranasal
- Route: into the nose, snorted or sprayed · clinical registerRoute of administration
- Intravenous
- Route: injected into a vein · abbreviation IVRoute of administration
- IV
- Abbreviation of Intravenous · use the target language's standard clinical abbreviationRoute of administration
667 matching source locations · Partial coverage
- 1,4-Butanediol · Field: legality.countries.Russia.notes
- 1P-LSD · Field: legality.countries.Czech Republic.designation
- 1P-LSD · Field: legality.countries.France.designation
- IV/IM
- Route label: intravenous or intramuscular injection · keep both abbreviations and the slashRoute of administration
2 matching source locations · Partial coverage
- Nausea suppression · Field: description_raw#6
- Piracetam · Field: legality.countries.Russia.notes
- Legal (regulated)
- Legal status: lawful to possess under rules such as age or licensing · pairs with Prescription only and RestrictedLegal status
206 matching source locations · Partial coverage
- 1,4-Butanediol · Field: legality.countries.Norway.status
- 5-Hydroxytryptophan · Field: legality.countries.Canada.status
- 5-Hydroxytryptophan · Field: legality.countries.Colombia.status
- Light
- Dose tier 2 of 5 · an amount, not brightness or weightDose tier
861 matching source locations · Partial coverage
- 1,4-Butanediol · Dosage > oral > Light
- 1B-LSD · Dosage > oral > Light
- 1cP-AL-LAD · Dosage > oral > Light
- Limited
- Evidence level: a few or weak studiesEvidence level
495 matching source locations · Partial coverage
- 1,4-Butanediol · Field: legality.countries.Netherlands.notes
- 1,4-Butanediol · Field: legality.countries.Norway.notes
- 1cP-LSD · Field: pharmacology.pharmacodynamics
- Low
- Risk level 2 of 4 · a rating, not a dose or a heightRisk level
466 matching source locations · Partial coverage
- 1B-LSD · Field: harm_potential.addiction.psychological.description
- 1B-LSD · Field: subjective_effects.sensory.visual.subcategories.Hallucinatory States.note
- 1cP-AL-LAD · Field: subjective_effects.sensory.visual.subcategories.Hallucinatory States.note
- Moderate
- Dose tier 3 of 5: the typical dose · an amount, not a temperamentDose tier
1328 matching source locations · Partial coverage
- 1,4-Butanediol · Dosage > oral > Moderate
- 1B-LSD · Dosage > oral > Moderate
- 1cP-AL-LAD · Dosage > oral > Moderate
- Negative
- Evidence level: studies contradict the claim · a direction, not a moodEvidence level
- No Evidence
- Carcinogenicity level: studied with no sign of cancer risk · not the same as UnknownCarcinogenicity level
27 matching source locations · Partial coverage
- 1cP-AL-LAD · Field: harm_potential.addiction.physical_dependence.description
- 1cP-MiPLA · Field: harm_potential.addiction.physical_dependence.description
- 2-FEA · Field: legality.countries.Netherlands.notes
- None
- Evidence level: no studies bear on the claim · absence of evidence, not a negative findingEvidence level
33 matching source locations · Partial coverage
- 2C-B-FLY · Field: legality.countries.Turkey.notes
- 2C-B-FLY-NBOMe · Field: legality.international[0]
- 2C-T-21 · Field: legality.countries.United States.notes
- Not scheduled
- Legal status: the substance appears in no controlled-drug schedule · absence of a rule, not permissionLegal status
- Offset
- Duration stage 4 of 6: effects declining · not compensation, not oppositeDuration stage
808 matching source locations · Partial coverage
- 1,4-Butanediol · Duration > oral > Offset
- 1B-LSD · Duration > oral > Offset
- 1cP-AL-LAD · Duration > oral > Offset
- Onset
- Duration stage 1 of 6: time until first effects are felt · a delay, not the effects themselvesDuration stage
973 matching source locations · Partial coverage
- 1,4-Butanediol · Duration > oral > Onset
- 1B-LSD · Duration > oral > Onset
- 1cP-AL-LAD · Duration > oral > Onset
- Oral
- Route of administration: swallowed · clinical register, not spokenRoute of administration
384 matching source locations · Partial coverage
- 1,4-Butanediol · Field: history_culture.sections[1].content
- 1B-LSD · Field: pharmacology.pharmacokinetics
- 1cP-LSD · Field: pharmacology.pharmacokinetics
- Peak
- Duration stage 3 of 6: strongest effects · a time span, not a mountain or maximum valueDuration stage
1048 matching source locations · Partial coverage
- 1,4-Butanediol · Duration > oral > Peak
- 1B-LSD · Duration > oral > Peak
- 1cP-AL-LAD · Duration > oral > Peak
- Positive
- Evidence level: studies support the claim · a direction, not a moodEvidence level
- Possible
- Carcinogenicity level: weak or limited evidence of cancer riskCarcinogenicity level
334 matching source locations · Partial coverage
- 1B-LSD · Field: interactions.caution[4]
- 1cP-AL-LAD · Field: interactions.caution[4]
- 1cP-LSD · Field: interactions.caution[4]
- Prescription only
- Legal status: lawful only with a medical prescriptionLegal status
719 matching source locations · Partial coverage
- 5-Hydroxytryptophan · Field: legality.countries.France.status
- Adrafinil · Field: legality.countries.Australia.status
- Adrafinil · Field: legality.countries.China.status
- Probable
- Carcinogenicity level: substantial evidence short of proof · stronger than PossibleCarcinogenicity level
5 matching source locations · Partial coverage
- 25c-NBOMe · Field: legality.countries.United States.notes
- Methylnaphthidate · Field: harm_potential.toxicity.organ_toxicity[0].notes
- Phenazepam · Field: pharmacology.pharmacokinetics
- Rectal
- Route: inserted into the rectum · clinical registerRoute of administration
- Restricted
- Legal status: lawful with limits on sale, amount, or place · not illegalLegal status
693 matching source locations · Partial coverage
- 1,4-Butanediol · Field: legality.countries.Belgium.status
- 1,4-Butanediol · Field: legality.countries.France.status
- 1,4-Butanediol · Field: legality.countries.Netherlands.status
- Smoked
- Route: burned and inhaled · combustion, not vaporisationRoute of administration
- Strong
- Dose tier 4 of 5 · an amount taken, not the potency of the substanceDose tier
1088 matching source locations · Partial coverage
- 1,4-Butanediol · Dosage > oral > Strong
- 1B-LSD · Dosage > oral > Strong
- 1cP-AL-LAD · Dosage > oral > Strong
- Subcutaneous
- Route: injected under the skinRoute of administration
13 matching source locations · Partial coverage
- 2C-B-FLY-NBOMe · Field: pharmacology.pharmacokinetics
- 4-HO-DiPT · Field: pharmacology.pharmacokinetics
- 4-HO-DiPT · Field: pharmacology.route_half_life_notes.Subcutaneous
- Sublingual
- Route: held under the tongue · not Buccal (cheek)Route of administration
- Threshold
- Dose tier 1 of 5: lowest dose with any noticeable effect · an amount, not a doorway or limitDose tier
1009 matching source locations · Partial coverage
- 1,4-Butanediol · Dosage > oral > Threshold
- 1B-LSD · Dosage > oral > Threshold
- 1cP-AL-LAD · Dosage > oral > Threshold
- Total
- Duration stage 6 of 6: the whole experience end to end · a length of time, not a quantityDuration stage
822 matching source locations · Partial coverage
- 1,4-Butanediol · Duration > oral > Total
- 1B-LSD · Duration > oral > Total
- 1cP-AL-LAD · Duration > oral > Total
- Transdermal
- Route: absorbed through intact skin, as a patch or gelRoute of administration
17 matching source locations · Partial coverage
- 3-FA · Field: pharmacology.pharmacokinetics
- Buprenorphine · Field: legality.countries.Switzerland.designation
- Datura · Field: pharmacology.pharmacokinetics
- Unknown
- Carcinogenicity level: not studied enough to say · not the same as No EvidenceCarcinogenicity level
- Unsafe
- Interaction tier 2 of 3: combination carries real risk and is advised againstInteraction tier
27 matching source locations · Partial coverage
- Acetylfentanyl · Field: interactions.dangerous[3]
- Acrylfentanyl · Field: interactions.dangerous[3]
- Buprenorphine · Field: interactions.dangerous[3]
- Vaporized
- Route: heated without burning and inhaled · not SmokedRoute of administration